封面
市場調查報告書
商品編碼
1190545

牙科生物材料市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Dental Biomaterials Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2021 年牙科生物材料市場價值約為 64.6475 億美元,預計到 2027 年將達到 94.8713 億美元,在 2022-2027 年的預測期內以 6.77% 的複合年增長率增長。我來了。

COVID-19 大流行對市場的影響很大,包括牙科護理在內的一些選擇性手術在大流行期間暫停或推遲。 2020 年 3 月,美國牙科協會 (ADA) 將所有選擇性牙科護理推遲到 2020 年 4 月 6 日,以防止患者給醫院急診科帶來過多負擔,從而推遲僅提供緊急牙科服務。建議提供 該公告於 2020 年 4 月 1 日更新,ADA 建議由於 COVID-19 病例增加,除緊急和急救外,診所關閉至 4 月 30 日。 結果,獲得牙科保健的機會大大減少。 而根據英國牙科協會公佈的數據,2020年7月,英國2053名牙醫中只有36%的人有條件恢復牙科執業。 在大流行的早期階段,牙科服務和治療的延遲減少了對牙科生物材料的需求,對市場增長產生了負面影響。 然而,隨著 COVID-19 的嚴重程度和感染率下降,隨著全球選擇性牙科護理的恢復,市場正在獲得吸引力。

此外,推動市場增長的主要因素包括牙科疾病負擔的增加、牙科旅遊的擴張、種植牙普及率的提高以及新興國家可支配收入的增加。

牙科疾病負擔的增加和牙科旅遊的增加是推動市場增長的主要因素。 牙周病、蛀牙、口腔癌、口臭和齲齒等牙科疾病負擔的增加是市場增長的推動力。 例如,根據世界衛生組織(WHO)2020年3月的最新信息,口腔疾病估計影響全球約35億人,其中嚴重的牙周(牙齦)疾病尤為常見。。 還有一篇標題為“牙科旅遊 2021”的文章。 2021 年 12 月在 Dentaly.org 上發表的“在國外獲得更便宜的牙科植入物和貼面”指出,牙科植入物旅遊是一項受成本節約□□推動的不斷增長的業務。 預計這些因素將在未來幾年推動牙科生物材料的需求,從而增加患者對牙科手術的採用。

然而,監管問題和治療成本是限制市場增長的因素之一。

牙科生物材料的市場趨勢

金屬生物材料板塊有望在預測期內快速增長

按類型劃分,金屬生物材料預計將顯著增長。 金屬生物材料是牙科中使用的一類主要材料。 這是由於與這些材料相關的高強度和其他機械性能。 這些生物材料由於鈦、鎵和矽等的承重和抗疲勞特性而被廣泛用於製造外科植入物。

在2021年11月發表的一篇題為“社論”的文章“Metallic Biomaterials for Medical Applications”中,與其他金屬植入材料相比,鈦合金具有優越的生物相容性、耐腐蝕性和比強度。因此,它被廣泛用作牙科材料和植入材料。 此外,根據 2020 年 8 月發表的論文“Review of Metallic Biomaterials in Dental Applications”,Ti-Ga-Si 將 Ti-Ga 合金的優點與 Si 相結合,為患者帶來了美觀的效果。據信可以增強骨整合,並具有最小的醫療並發症的可能性。

此類研究將對該細分市場的增長產生積極影響,因為它證明了金屬生物材料的有效性,並有望創造對金屬植入物的巨大需求。

北美有望在預測期內實現高增長

在北美地區,美國有望實現顯著增長。 政府機構支持的產品發布增加、牙科疾病負擔增加以及老年人口不斷增加正在推動美國對牙科生物材料的需求。

例如,根據美國牙科協會的數據,到 2020 年,將有超過 500 萬年齡在 65 至 74 歲之間的美國人完全沒有牙齒,近 300 萬將患有無牙頜。 另一方面,掉牙主要是老年人的問題。 由於 91% 的 20-64 歲成年人有蛀牙,其中 27% 未接受治療。 此外,因蛀牙而導致牙齒脫落的案例也很多。 因此,預計這些因素將增加美國進行的牙科手術總數,從而增加國內對牙科生物材料的需求。

此外,一些市場參與者也參與實施戰略計劃,從而推動市場增長。 例如,2020 年 1 月,位於大波士頓地區的牙科研究和製造公司 Pulpdent Corporation 推出了 ACTIVA Presto 牙科材料。 這種新型白色牙科填充材料模仿了天然牙齒的特性。 此外,2021 年 4 月,高科技牙科材料和設備的開發商和製造商 Ultradent Products 將收購墨西哥牙科產品藍籌分銷商 Vamasa SA de CV 的多數股權。底部。

因此,考慮到上述因素,預計該市場在預測期內將出現顯著增長。

牙科生物材料市場競爭分析

由於國內外參與者的存在,牙科生物材料市場競爭激烈。 大部分市場份額被全球玩家佔據,而中小企業則在新技術的幫助下展開激烈的競爭。 未來,隨著新進入者開發創新產品,市場份額有望在國際和小型企業之間實現多元化。 主要參與者包括 Straumann Holding AG、Dentsply Sirona Inc.、3M Company、ZimVie Inc. 和 Botiss Biomaterials GmbH。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 調查結果
  • 調查假設
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 牙科疾病負擔的增加和牙科旅遊的擴大
    • 提高種植牙的滲透率
    • 新興國家的可支配收入增加
  • 市場製約因素
    • 監管問題
    • 治療費用
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模 - 百萬美元)

  • 按類型
    • 金屬生物材料
      • 不銹鋼
      • 鉻合金
      • 其他金屬生物材料
    • 陶瓷生物材料
    • 高分子生物材料
    • 天然生物材料
    • 其他類型
  • 通過使用
    • 牙齒矯正
    • 假牙
    • 其他用途
  • 最終用戶
    • 醫院和診所
    • 學術和研究機構
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • GC Corporation
    • Victrex PLC
    • Medtronic PLC
    • Straumann Holding AG
    • ZimVie Inc.
    • Dentsply Sirona Inc.
    • Royal DSM
    • Danaher Corporation
    • 3M Company
    • Bay Materials
    • Vannini Dental Industry SRL
    • Kyocera Corporation
    • Botiss Biomaterials GmbH

第7章 市場機會今後動向

簡介目錄
Product Code: 67115

The dental biomaterials market was valued at about USD 6,464.75 million in 2021, and it is expected to reach USD 9,487.13 million by 2027, recording a CAGR of 6.77% over the forecast period 2022-2027.

The impact of the COVID-19 pandemic on the market was significant as several elective procedures, including dental treatments, were halted or postponed during the pandemic. In March 2020, the American Dental Association (ADA) recommended postponing all elective dental procedures until April 6, 2020, and providing emergency-only dental services to keep patients from burdening hospital emergency departments. This recommendation was updated on April 1, 2020, when the ADA advised offices to remain closed except for urgent and emergency procedures until April 30, owing to the rise of COVID-19 cases. As a result, access to dental care substantially decreased. Also, as per data published by the British Dental Association, in July 2020, out of 2,053 dentists, only 36% were ready to resume dental practices in United Kingdom. ​During the initial phase of the pandemic, dental services and treatments were delayed, which resulted in decreased demand for dental biomaterials and affected market growth adversely. However, the market is gaining traction as elective dental procedures have resumed worldwide owing to the declining severity and infections of COVID-19.

Further, the major factors fueling the market growth include the rising burden of dental disorders, growing dental tourism, growing penetration of dental implants, and increasing disposable income across developing countries.

The rising burden of dental disorders and growing dental tourism are major factors driving the market growth. The growing burden of dental diseases such as periodontal disease, tooth decay, oral cancer, halitosis, and dental caries, among other diseases, is driving the market growth. For instance, as per a March 2020 update by the World Health Organization (WHO), it is estimated that oral diseases affect nearly 3.5 billion people globally, especially severe periodontal (gum) disease. Also, an article titled "Dental Tourism 2021: Get Cheaper Dental Implants and Veneers Abroad," published in Dentaly.org in December 2021, stated that dental implant tourism is a growing business attributed to cost savings. Such factors are thereby increasing the adoption of dental procedures among patients and are expected to drive the demand for dental biomaterials over the coming years.

Nevertheless, regulatory issues and the cost of procedures are some of the factors restraining the market growth.

Dental Biomaterials Market Trends

Metallic Biomaterials Segment Expected to Witness High Growth over the Forecast Period

By type, metallic biomaterials are expected to witness significant growth. Metallic biomaterials are a central class of materials for use in dental treatments. This can be attributed to the high strength and other mechanical properties associated with these materials. These biomaterials are extensively used to fabricate surgical implants owing to load-bearing characteristics and fatigue properties, such as titanium, gallium, and silicon.

​As per an article published in November 2021, titled "Editorial: Metallic Biomaterials for Medical Applications," titanium alloys are widely used for dental and implant materials due to their superior biocompatibility, corrosion resistance, and specific strength compared with other metallic implant materials. In addition, as per an article titled, "Review of Metallic Biomaterials in Dental Applications," published in August 2020, Ti-Ga-Si is considered to combine the advantages of the Ti-Ga alloy along with Si, which enhances the osseointegration with aesthetically pleasing outcomes for patients and minimal likelihood of medical complications.

Such studies indicate the efficacy of metallic biomaterials and are expected to generate significant demand for metallic implants, thus positively impacting the segment's growth.​

North America Expected to Witness High Growth over the Forecast Period

Within North America, United States is expected to observe significant growth. With the increase in product launches supported by government authorities, the rising burden of dental diseases and the increasing geriatric population are bolstering the demand for dental biomaterials in United States.​

For instance, as per the American Dental Association, in 2020, more than 5 million US seniors aged 65 to 74 had complete tooth loss, with nearly 3 million suffering from edentulous. Tooth loss, on the other hand, is primarily a problem for the elderly. This is because 91% of adults aged 20 to 64 have dental caries, with a staggering 27% going untreated. Furthermore, tooth decay is a common cause of tooth loss in many cases. Thus, such factors are anticipated to boost the total dental procedures performed across United States, thereby boosting the demand for dental biomaterials within the country.

​Furthermore, several market players are also engaged in implementing strategic initiatives, thereby propelling market growth. For instance, in January 2020, Pulpdent Corporation, a dental research and manufacturing company based in the Greater Boston area, launched its ACTIVA Presto dental material. The new white dental filling material mimics the properties of natural teeth. ​Moreover, in April 2021, Ultradent Products Inc., a developer and manufacturer of high-tech dental materials and equipment, purchased majority ownership in Vamasa SA de CV, a premier distributor of dental products in Mexico.

Thus, in view of the abovementioned factors, the market is expected to witness significant growth in the region over the forecast period.

Dental Biomaterials Market Competitive Analysis

The dental biomaterials market is moderately competitive, with the presence of local and international players in the market. The major share of the market has been grabbed by global players, whereas small to mid-sized companies are posing intense competition with the help of novel technologies. In the future, it is expected that the market share will be distributed among international players and small players as well due to the focus of new entrants to come up with innovative products. Some of the major players in the market are Straumann Holding AG, Dentsply Sirona Inc., 3M Company, ZimVie Inc., and Botiss Biomaterials GmbH.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Dental Disorders and Growing Dental Tourism
    • 4.2.2 Increasing Penetration of Dental Implants
    • 4.2.3 Increase in Disposable Incomes across Developing Countries
  • 4.3 Market Restraints
    • 4.3.1 Regulatory Isssues
    • 4.3.2 Cost of the Procedure
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Type
    • 5.1.1 Metallic Biomaterials
      • 5.1.1.1 Titanium
      • 5.1.1.2 Stainless Steel
      • 5.1.1.3 Chromium Alloys
      • 5.1.1.4 Other Metallic Biomaterials
    • 5.1.2 Ceramic Biomaterials
    • 5.1.3 Polymeric Biomaterials
    • 5.1.4 Natural Biomaterials
    • 5.1.5 Other Types
  • 5.2 By Application
    • 5.2.1 Orthodontics
    • 5.2.2 Prosthodontics
    • 5.2.3 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Academies and Research Institutes
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 GC Corporation
    • 6.1.2 Victrex PLC
    • 6.1.3 Medtronic PLC
    • 6.1.4 Straumann Holding AG
    • 6.1.5 ZimVie Inc.
    • 6.1.6 Dentsply Sirona Inc.
    • 6.1.7 Royal DSM
    • 6.1.8 Danaher Corporation
    • 6.1.9 3M Company
    • 6.1.10 Bay Materials
    • 6.1.11 Vannini Dental Industry SRL
    • 6.1.12 Kyocera Corporation
    • 6.1.13 Botiss Biomaterials GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS